158 related articles for article (PubMed ID: 15715462)
1. Three-dimensional structure-activity relationships of nonsteroidal ligands in complex with androgen receptor ligand-binding domain.
Söderholm AA; Lehtovuori PT; Nyrönen TH
J Med Chem; 2005 Feb; 48(4):917-25. PubMed ID: 15715462
[TBL] [Abstract][Full Text] [Related]
2. Docking and three-dimensional quantitative structure-activity relationship (3D QSAR) analyses of nonsteroidal progesterone receptor ligands.
Söderholm AA; Lehtovuori PT; Nyrönen TH
J Med Chem; 2006 Jul; 49(14):4261-8. PubMed ID: 16821785
[TBL] [Abstract][Full Text] [Related]
3. QSAR study of a large set of 3-pyridyl ethers as ligands of the alpha4beta2 nicotinic acetylcholine receptor.
Zhang H; Li H; Ma Q
J Mol Graph Model; 2007 Jul; 26(1):226-35. PubMed ID: 17208024
[TBL] [Abstract][Full Text] [Related]
4. Computationally identified novel diphenyl- and phenylpyridine androgen receptor antagonist structures.
Söderholm AA; Viiliäinen J; Lehtovuori PT; Eskelinen H; Roell D; Baniahmad A; Nyrönen TH
J Chem Inf Model; 2008 Sep; 48(9):1882-90. PubMed ID: 18712859
[TBL] [Abstract][Full Text] [Related]
5. Receptor-based 3D-QSAR studies of checkpoint Wee1 kinase inhibitors.
Wichapong K; Lindner M; Pianwanit S; Kokpol S; Sippl W
Eur J Med Chem; 2009 Apr; 44(4):1383-95. PubMed ID: 18976834
[TBL] [Abstract][Full Text] [Related]
6. Effects of steroidal and non-steroidal antiandrogens on wild-type and mutant androgen receptors.
Urushibara M; Ishioka J; Hyochi N; Kihara K; Hara S; Singh P; Isaacs JT; Kageyama Y
Prostate; 2007 Jun; 67(8):799-807. PubMed ID: 17373727
[TBL] [Abstract][Full Text] [Related]
7. Receptor-guided alignment-based comparative 3D-QSAR studies of benzylidene malonitrile tyrphostins as EGFR and HER-2 kinase inhibitors.
Kamath S; Buolamwini JK
J Med Chem; 2003 Oct; 46(22):4657-68. PubMed ID: 14561085
[TBL] [Abstract][Full Text] [Related]
8. Interpretation of scoring functions using 3D molecular fields. Mapping the diacyl-hydrazine-binding pocket of an insect ecdysone receptor.
Bordas B; Belai I; Lopata A; Szanto Z
J Chem Inf Model; 2007; 47(1):176-85. PubMed ID: 17238263
[TBL] [Abstract][Full Text] [Related]
9. Key structural features of nonsteroidal ligands for binding and activation of the androgen receptor.
Yin D; He Y; Perera MA; Hong SS; Marhefka C; Stourman N; Kirkovsky L; Miller DD; Dalton JT
Mol Pharmacol; 2003 Jan; 63(1):211-23. PubMed ID: 12488554
[TBL] [Abstract][Full Text] [Related]
10. A ligand-based approach to identify quantitative structure-activity relationships for the androgen receptor.
Bohl CE; Chang C; Mohler ML; Chen J; Miller DD; Swaan PW; Dalton JT
J Med Chem; 2004 Jul; 47(15):3765-76. PubMed ID: 15239655
[TBL] [Abstract][Full Text] [Related]
11. Exploration of a binding mode of indole amide analogues as potent histone deacetylase inhibitors and 3D-QSAR analyses.
Guo Y; Xiao J; Guo Z; Chu F; Cheng Y; Wu S
Bioorg Med Chem; 2005 Sep; 13(18):5424-34. PubMed ID: 15963726
[TBL] [Abstract][Full Text] [Related]
12. The androgen receptor T877A mutant recruits LXXLL and FXXLF peptides differently than wild-type androgen receptor in a time-resolved fluorescence resonance energy transfer assay.
Ozers MS; Marks BD; Gowda K; Kupcho KR; Ervin KM; De Rosier T; Qadir N; Eliason HC; Riddle SM; Shekhani MS
Biochemistry; 2007 Jan; 46(3):683-95. PubMed ID: 17223690
[TBL] [Abstract][Full Text] [Related]
13. Anti-androgen activity of polybrominated diphenyl ethers determined by comparative molecular similarity indices and molecular docking.
Yang W; Mu Y; Giesy JP; Zhang A; Yu H
Chemosphere; 2009 May; 75(9):1159-64. PubMed ID: 19324393
[TBL] [Abstract][Full Text] [Related]
14. Docking ligands onto binding site representations derived from proteins built by homology modelling.
Schafferhans A; Klebe G
J Mol Biol; 2001 Mar; 307(1):407-27. PubMed ID: 11243828
[TBL] [Abstract][Full Text] [Related]
15. 3D-QSAR and molecular docking studies of selective agonists for the thyroid hormone receptor beta.
Du J; Qin J; Liu H; Yao X
J Mol Graph Model; 2008 Sep; 27(2):95-104. PubMed ID: 18436460
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis of agonicity and antagonicity in the androgen receptor studied by molecular dynamics simulations.
Bisson WH; Abagyan R; Cavasotto CN
J Mol Graph Model; 2008 Nov; 27(4):452-8. PubMed ID: 18805032
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for androgen receptor agonists and antagonists: interaction of SPEED 98-listed chemicals and related compounds with the androgen receptor based on an in vitro reporter gene assay and 3D-QSAR.
Tamura H; Ishimoto Y; Fujikawa T; Aoyama H; Yoshikawa H; Akamatsu M
Bioorg Med Chem; 2006 Nov; 14(21):7160-74. PubMed ID: 16876421
[TBL] [Abstract][Full Text] [Related]
18. Structural and chemical basis for enhanced affinity and potency for a large series of estrogen receptor ligands: 2D and 3D QSAR studies.
Salum Lde B; Polikarpov I; Andricopulo AD
J Mol Graph Model; 2007 Sep; 26(2):434-42. PubMed ID: 17349808
[TBL] [Abstract][Full Text] [Related]
19. 3D-QSAR studies of boron-containing dipeptides as proteasome inhibitors with CoMFA and CoMSIA methods.
Zhu YQ; Lei M; Lu AJ; Zhao X; Yin XJ; Gao QZ
Eur J Med Chem; 2009 Apr; 44(4):1486-99. PubMed ID: 18771818
[TBL] [Abstract][Full Text] [Related]
20. 3D QSAR studies on protein tyrosine phosphatase 1B inhibitors: comparison of the quality and predictivity among 3D QSAR models obtained from different conformer-based alignments.
Pandey G; Saxena AK
J Chem Inf Model; 2006; 46(6):2579-90. PubMed ID: 17125198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]